Unknown

Dataset Information

0

Neutrophil Gelatinase-Associated Lipocalin and its Receptors in Alzheimer's Disease (AD) Brain Regions: Differential Findings in AD with and without Depression.


ABSTRACT: Co-existing depression worsens Alzheimer's disease (AD) pathology. Neutrophil gelatinase-associated lipocalin (NGAL) is a newly identified (neuro)inflammatory mediator in the pathophysiologies of both AD and depression. This study aimed to compare NGAL levels in healthy controls, AD without depression (AD-D), and AD with co-existing depression (AD+D) patients. Protein levels of NGAL and its receptors, 24p3R and megalin, were assessed in nine brain regions from healthy controls (n?=?19), AD-D (n?=?19), and AD+D (n?=?21) patients. NGAL levels in AD-D patients were significantly increased in brain regions commonly associated with AD. In the hippocampus, NGAL levels were even further increased in AD+D subjects. Unexpectedly, NGAL levels in the prefrontal cortex of AD+D patients were comparable to those in controls. Megalin levels were increased in BA11 and amygdala of AD+D patients, while no changes in 24p3R were detected. These findings indicate significant differences in neuroimmunological regulation between AD patients with and without co-existing depression. Considering its known effects, elevated NGAL levels might actively promote neuropathological processes in AD with and without depression.

SUBMITTER: Dekens DW 

PROVIDER: S-EPMC5147520 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

altmetric image

Publications

Neutrophil Gelatinase-Associated Lipocalin and its Receptors in Alzheimer's Disease (AD) Brain Regions: Differential Findings in AD with and without Depression.

Dekens Doortje W DW   Naudé Petrus J W PJ   Engelborghs Sebastiaan S   Vermeiren Yannick Y   Van Dam Debby D   Oude Voshaar Richard C RC   Eisel Ulrich L M UL   De Deyn Peter P PP  

Journal of Alzheimer's disease : JAD 20170101 2


Co-existing depression worsens Alzheimer's disease (AD) pathology. Neutrophil gelatinase-associated lipocalin (NGAL) is a newly identified (neuro)inflammatory mediator in the pathophysiologies of both AD and depression. This study aimed to compare NGAL levels in healthy controls, AD without depression (AD-D), and AD with co-existing depression (AD+D) patients. Protein levels of NGAL and its receptors, 24p3R and megalin, were assessed in nine brain regions from healthy controls (n = 19), AD-D (n   ...[more]

Similar Datasets

| S-EPMC5014392 | biostudies-literature
| S-EPMC7798090 | biostudies-literature
| S-EPMC4039233 | biostudies-literature
| S-EPMC1276944 | biostudies-other
| S-EPMC4562555 | biostudies-literature
| S-EPMC4858300 | biostudies-literature
| S-EPMC6658088 | biostudies-literature
| S-EPMC10970073 | biostudies-literature
| S-EPMC6828964 | biostudies-literature
| S-EPMC5259624 | biostudies-literature